Literature DB >> 33405562

Insulin-Loaded Silk Fibroin Microneedles as Sustained Release System.

Shiyi Wang1, Mingmei Zhu1, Liang Zhao1, Dajiang Kuang1, Subhas C Kundu2, Shenzhou Lu1.   

Abstract

Silk fibroin has widely been used in biomedical applications for its excellent biocompatibility, degradability, and mechanical properties. Microneedles are a suitable method for transdermal drug delivery. In this work, we have prepared microneedles using silk fibroin as the main material and have added proline to change its crystal structure. The fabricated microneedles are nontoxic and degradable and show relatively slow drug release. Our results indicate that the fibroin/proline microneedles can act as carriers of insulin. Fourier transform infrared (FTIR) observations show that the structure of proline-treated fibroin is transformed from random coils to β-sheets. A more regular arrangement is formed between the molecular segments. X-ray diffraction patterns show that proline has good compatibility with fibroin and induces the secondary conformation of the microneedles to a Silk I type structure. The needles have enough strength to pierce the stratum corneum of the skin. In vitro release experiments with insulin indicate that the release time from the microneedles is maintained up to 60 h. This system of delivery may provide a painless and effective route of insulin intake for the treatment of diabetic patients.

Entities:  

Keywords:  controlled release; insulin; microneedles; silk fibroin

Year:  2019        PMID: 33405562     DOI: 10.1021/acsbiomaterials.9b00229

Source DB:  PubMed          Journal:  ACS Biomater Sci Eng        ISSN: 2373-9878


  9 in total

Review 1.  Challenges in delivering therapeutic peptides and proteins: A silk-based solution.

Authors:  Junqi Wu; Jugal Kishore Sahoo; Yamin Li; Qiaobing Xu; David L Kaplan
Journal:  J Control Release       Date:  2022-02-11       Impact factor: 11.467

2.  pH-Responsive Cellulose-Based Microspheres Designed as an Effective Oral Delivery System for Insulin.

Authors:  Yaqi Gong; Shabbir Mohd; Simei Wu; Shilin Liu; Ying Pei; Xiaogang Luo
Journal:  ACS Omega       Date:  2021-01-25

Review 3.  Microneedle-based insulin transdermal delivery system: current status and translation challenges.

Authors:  Jing Zhao; Genying Xu; Xin Yao; Huirui Zhou; Boyang Lyu; Shuangshuang Pei; Ping Wen
Journal:  Drug Deliv Transl Res       Date:  2021-10-20       Impact factor: 5.671

4.  Silk/polyols/GOD microneedle based electrochemical biosensor for continuous glucose monitoring.

Authors:  Liang Zhao; Zhuangzhuang Wen; Fujian Jiang; Zhaozhu Zheng; Shenzhou Lu
Journal:  RSC Adv       Date:  2020-02-10       Impact factor: 4.036

5.  Elucidating the Impact of Surfactants on the Performance of Dissolving Microneedle Array Patches.

Authors:  Qonita Kurnia Anjani; Akmal Hidayat Bin Sabri; Emilia Utomo; Juan Domínguez-Robles; Ryan F Donnelly
Journal:  Mol Pharm       Date:  2022-03-02       Impact factor: 5.364

Review 6.  Novel Pharmaceutical Strategies for Enhancing Skin Penetration of Biomacromolecules.

Authors:  Luyu Zhang; Zirong Dong; Wenjuan Liu; Xiying Wu; Haisheng He; Yi Lu; Wei Wu; Jianping Qi
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-16

7.  Fabrication of a magnetic alginate-silk fibroin hydrogel, containing halloysite nanotubes as a novel nanocomposite for biological and hyperthermia applications.

Authors:  Reza Eivazzadeh-Keihan; Zahra Sadat; Hooman Aghamirza Moghim Aliabadi; Fatemeh Ganjali; Amir Kashtiaray; Milad Salimi Bani; Samira Komijani; Mohammad Mahdi Ahadian; Nabi Salehpour; Reza Ahangari Cohan; Ali Maleki
Journal:  Sci Rep       Date:  2022-09-14       Impact factor: 4.996

8.  Synthesis of pH and Glucose Responsive Silk Fibroin Hydrogels.

Authors:  Xiaosheng Tao; Fujian Jiang; Kang Cheng; Zhenzhen Qi; Vamsi K Yadavalli; Shenzhou Lu
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

9.  Silk Fibroin Microneedle Patches for the Treatment of Insomnia.

Authors:  Zhenzhen Qi; Jiaxin Cao; Xiaosheng Tao; Xinyi Wu; Subhas C Kundu; Shenzhou Lu
Journal:  Pharmaceutics       Date:  2021-12-20       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.